Literature DB >> 6540756

A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.

C A Grotendorst, N Kumar, R Carter, D C Kaushal.   

Abstract

Antibodies against gametes of malarial parasites (Plasmodium spp.) have previously been shown to block infectivity of the parasites to mosquitoes by preventing fertilization of the parasites in the insect midgut. These antibodies did not have any effect on the development of fertilized parasites. We now report that a surface protein of Mr 26,000 synthesized by zygotes of P. gallinaceum is the target of antibodies which block infectivity of the fertilized parasites to mosquitoes. Identification of this target antigen offers a new stage of the parasite against which a malaria transmission-blocking vaccine could be developed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540756      PMCID: PMC263365          DOI: 10.1128/iai.45.3.775-777.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro.

Authors:  M M Nijhout; R Carter
Journal:  Parasitology       Date:  1978-02       Impact factor: 3.234

2.  Successful immunization against the sexual stages of Plasmodium gallinaceum.

Authors:  R W Gwadz
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

3.  Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor.

Authors:  M M Nijhout
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

4.  Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations.

Authors:  R Carter; R W Gwadz; F M McAuliffe
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

5.  Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens.

Authors:  D C Kaushal; R Carter; R J Howard; F M McAuliffe
Journal:  Mol Biochem Parasitol       Date:  1983-05       Impact factor: 1.759

6.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

7.  Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.

Authors:  D C Kaushal; R Carter; J Rener; C A Grotendorst; L H Miller; R J Howard
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes.

Authors:  D C Kaushal; R Carter
Journal:  Mol Biochem Parasitol       Date:  1984-04       Impact factor: 1.759

9.  Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.

Authors:  J Rener; P M Graves; R Carter; J L Williams; T R Burkot
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  9 in total
  19 in total

1.  Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

Authors:  B Wizel; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei.

Authors:  N Tirawanchai; L A Winger; J Nicholas; R E Sinden
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

Review 4.  Malaria vaccines since 2000: progress, priorities, products.

Authors:  Patrick E Duffy; J Patrick Gorres
Journal:  NPJ Vaccines       Date:  2020-06-09       Impact factor: 7.344

5.  Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

Authors:  Issaka Sagara; Sara A Healy; Mahamadoun H Assadou; Erin E Gabriel; Mamady Kone; Kourane Sissoko; Intimbeye Tembine; Merepen A Guindo; M'Bouye Doucoure; Karamoko Niaré; Amagana Dolo; Kelly M Rausch; David L Narum; David L Jones; Nicholas J MacDonald; Daming Zhu; Rathy Mohan; Olga Muratova; Ibrahima Baber; Mamadou B Coulibaly; Michael P Fay; Charles Anderson; Yimin Wu; Sekou F Traore; Ogobara K Doumbo; Patrick E Duffy
Journal:  Lancet Infect Dis       Date:  2018-07-27       Impact factor: 25.071

Review 6.  Comparative biology of intracellular parasitism.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1985-09

7.  Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity.

Authors:  T Tsuboi; Y M Cao; Y Hitsumoto; T Yanagi; H Kanbara; M Torii
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.

Authors:  D C Kaslow; I C Bathurst; T Lensen; T Ponnudurai; P J Barr; D B Keister
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Transfection of the malaria parasite and expression of firefly luciferase.

Authors:  R Goonewardene; J Daily; D Kaslow; T J Sullivan; P Duffy; R Carter; K Mendis; D Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.